Nothing Special   »   [go: up one dir, main page]

EP3616675B1 - Réservoir de stockage pour une station de stockage et de distribution pour médicament - Google Patents

Réservoir de stockage pour une station de stockage et de distribution pour médicament Download PDF

Info

Publication number
EP3616675B1
EP3616675B1 EP18191874.9A EP18191874A EP3616675B1 EP 3616675 B1 EP3616675 B1 EP 3616675B1 EP 18191874 A EP18191874 A EP 18191874A EP 3616675 B1 EP3616675 B1 EP 3616675B1
Authority
EP
European Patent Office
Prior art keywords
section
projections
storage
wall
storage container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18191874.9A
Other languages
German (de)
English (en)
Other versions
EP3616675A1 (fr
Inventor
Dietmar Gross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson Rowa Germany GmbH
Original Assignee
Becton Dickinson Rowa Germany GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Rowa Germany GmbH filed Critical Becton Dickinson Rowa Germany GmbH
Priority to EP18191874.9A priority Critical patent/EP3616675B1/fr
Priority to JP2021510868A priority patent/JP7304938B2/ja
Priority to CN201980056289.XA priority patent/CN112638346B/zh
Priority to KR1020217005501A priority patent/KR102694096B1/ko
Priority to PCT/EP2019/063515 priority patent/WO2020043334A1/fr
Publication of EP3616675A1 publication Critical patent/EP3616675A1/fr
Application granted granted Critical
Publication of EP3616675B1 publication Critical patent/EP3616675B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B39/00—Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
    • B65B39/007—Guides or funnels for introducing articles into containers or wrappers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B5/00—Packaging individual articles in containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, jars
    • B65B5/10—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles
    • B65B5/101—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity
    • B65B5/103—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity for packaging pills or tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
    • B65B9/02—Enclosing successive articles, or quantities of material between opposed webs
    • B65B9/04—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material
    • B65B9/045—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material for single articles, e.g. tablets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F11/00—Coin-freed apparatus for dispensing, or the like, discrete articles
    • G07F11/005—Special arrangements for insuring that only one single article may be dispensed at a time
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F11/00—Coin-freed apparatus for dispensing, or the like, discrete articles
    • G07F11/02—Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines
    • G07F11/44—Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines in which magazines the articles are stored in bulk
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
    • G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles

Definitions

  • the present invention relates to a storage container for a storage and dispensing station for drugs.
  • Modern blister machines such as those in the WO 2013/034504 A1 are disclosed, include, depending on the expansion stage, several hundred storage and dispensing stations for drugs. A plurality of medicament portions of a certain type of medicament are stored in each of these, and single or multiple medicament portions can be dispensed upon request. With the automatic blister packs, the drugs stored in the supply and dispensing stations are individually compiled and blistered for each patient according to the times prescribed by the doctor.
  • corresponding storage and dispensing stations for dispensing one or more individual drug portions are controlled.
  • a singling device separates a single drug portion and transfers it to a guide device of the blister machine via a dispensing opening.
  • a dispensed medicament portion is fed to a packaging device, possibly with the interposition of a collecting device, which blisters individual or several medicament portions in accordance with the medical specifications.
  • the separating device used for separating medicament portions is usually designed in the shape of a circular cylinder and is designed in a corresponding guide space of the storage container.
  • a plurality of medicament channels are provided on the circumference of the separating device, via which medicament portions of the dispensing opening in a bottom surface of the Reservoir are supplied. Projections are formed between the individual medicament channels, which are formed in one piece with a main body of the separating device or can be releasably fastened to the latter.
  • the projections regularly have a circular-arc-shaped outer surface, which abut against an inner wall of the guide space in which the separating device is arranged (in the context of this application, the term "abut” does not mean that a The entire surface touches another, but that, if necessary, a small (annular) gap is formed at least in sections). If a surrounding area is placed around the outer circumferential surfaces of the projections, a circle results, the radius of which is only slightly smaller than the radius of the receiving space. In the prior art (neglecting the drug channels), the separating devices thus have a circular base area.
  • a large number of medicament portions are arranged in each of the storage containers for the storage and dispensing stations.
  • the singling device is rotated through a certain angle in order to feed a medicament portion arranged in a medicament channel to the dispensing opening.
  • these rub against one another as well as against the components of the storage container during the separation. This leads to flaking of the drug portions and a kind of drug dust forms. This settles on all components of the storage container, including on the wall of the guide section in which the separating device is arranged.
  • the object is achieved according to the invention by a storage container according to claim 1.
  • the storage container according to the invention for a storage and dispensing station for medicament portions comprises a housing which encloses a receiving space for medicament portions and has a guide section and a bottom surface, an inner wall of the guide section defining a circular-cylindrical guide space the bottom surface has a dispensing opening.
  • a separation device with a central axis of rotation is arranged in the guide section of the housing.
  • the separating device comprises a central main section and a plurality of projections, each projection having two end sections and a central section, and wherein a medicament channel is formed in each case between two end sections of adjacent projections.
  • the projections can be designed to be flatter than the main body of the guide device, which supports the feeding of the medicament portions to the medicament channels.
  • the outer jacket surface is regularly circular arc-shaped (with respect to a central axis of rotation) and the projections therefore form a type of hollow cylinder (if the drug channels are neglected), the outer jacket surface of which rests against the inner wall of the guide section.
  • the projections are designed differently. It is provided according to the invention that the middle sections of the projections are withdrawn with respect to at least one of the end sections and the at least one end section of each projection is designed in such a way that its outer surface rests against the wall of the guide section (in the context of this application, the term " Concerning "does not mean that one surface is in full contact with another, but that if necessary, at least in sections, a narrow or small (annular) gap is formed which enables rotation of the separating device).
  • the projections rest against the wall with only a small section (or are slightly spaced from this) and, if necessary, are guided by or on this, whereby it is provided according to the invention that it This section is an end section to which a drug channel is connected.
  • This section is an end section to which a drug channel is connected.
  • only a small part of the surface area of the projections rests against the wall of the guide section, namely the sum of the aforementioned end sections.
  • the middle sections of the projections are "withdrawn” with respect to the end sections, that is to say, viewed radially, do not extend as far to the wall as at least one of the end sections of each projection.
  • a (wider) gap is provided between the wall and the middle section.
  • the term “gap” in the middle sections only means that the distance between the wall and the outer surface of the middle section is greater than the distance between the wall and the outer surface of the end section. If the middle sections are arcuate, this means that that the gap between the wall and the middle section is designed like a segment of a hollow cylinder. Alternatively, the middle section can also be designed like a kind of secant in relation to the wall, as a result of which the gap would then rather have the shape of a segment of a circle.
  • a corresponding design of the projections has the result that drug dust generated during the isolation can trickle down through the gap in the area of the central sections and is thus quickly led to the bottom surface, where it can be guided to a receiving opening in the bottom surface with a corresponding design of the bottom surface.
  • the design of the projections according to the invention results in a reduced friction surface of the wall / separating device, and the force to be used to rotate the separating device is lower. It is essential here that the force that is necessary to rotate the separating device in the guide section changes only slightly, even with increased drug dust formation, since less drug dust adheres to the wall. Since the force to be used for rotation changes only slightly when dust is formed, the separating device can be controlled or rotated more precisely. The probability of incorrect deliveries (for example due to poor alignment of a drug channel at the delivery opening) is reduced with the storage container according to the invention.
  • the design of the projections according to the invention has a further considerable advantage.
  • drug dust falls in the area of the drug channels
  • the proportion of drug dust falling in the channels is reduced in relation to the total amount of drug dust, so that less drug dust reaches (and through) the dispensing opening in the Floor area.
  • the entry of medicament dust into the automatic blister pack is avoided, which extends the time intervals between cleaning caused by medicament dust and thus reduces the downtime of the automatic blister pack.
  • the projections Due to the shape of the projections, they always have two end sections, each of these end sections adjoining a drug channel. At least one of these end sections rests against the wall of the guide section, that is to say has a larger "radius" than the withdrawn central section. How exactly the second end section is designed is not essential for the functioning of the invention. Rather, it is essential that end sections resting against the wall allow a uniform and impact-free, low-friction rotation of the separating device in the guide section, which is regularly the case with three corresponding end sections (possibly even with two end sections if they are correspondingly wide).
  • the end sections are uniformly distributed in all projections. If only one such end section is provided per projection, this means that these end sections (viewed from the axis of rotation) are always arranged on the right or left of the projection. Depending on the direction of rotation, the end sections resting on the wall (hereinafter briefly “protruding” end sections; “protruding” in relation to the central section) are then arranged “rear” or "front” on the projection.
  • the direction of rotation is regularly selected so that the protruding end sections are "at the rear", that is, a drug channel follows an end section. If you turn the direction of rotation, the end sections lie at the projections "front”, so follow a drug channel in the direction of rotation.
  • both end sections of a projection are designed in such a way that they rest against the wall of the guide section.
  • Appropriate training improves the delivery of a drug portion into the drug channel.
  • the end sections of the projections resting on the wall of the guide section regardless of whether one or both projections are designed accordingly, are symmetrically distributed over the separating device. If three drug channels and thus three projections are provided, this means that the drug channels are each offset by a central angle of 120 ° with respect to the axis of rotation.
  • the projections have a non-stick coating at least in the area of the central section on a lateral surface facing the wall.
  • a preferred embodiment provides for the separating device to have a conical surface with a plurality of depressions aligned with the drug channels.
  • the main section has recesses above the medicament channels.
  • Figures 1a and 1b show two oblique views of a preferred first embodiment of the storage container 1 for a storage and dispensing station for drugs.
  • the storage container 1 according to the invention is part of the aforementioned storage and delivery station, the storage container usually being detachably arranged on a delivery station (not shown).
  • components can be arranged in the storage container or the delivery station.
  • Figure 1b can be seen, which shows the storage container from below, this does not include a motor in the embodiment shown, but only a coupling piece 31, via which a separating device (shown in more detail in the following figures) can be coupled to a motor in the delivery station.
  • the storage container 1 comprises a housing 10 with a circular cylindrical section 11, to which a bottom section 12 adjoins at the bottom.
  • the bottom section 12 is connected to the upper part of the housing via a handle 13 with which the storage container 1 can be taken from a corresponding dispensing station.
  • a circular recess 22 is arranged around the coupling piece 31, which is described in more detail in the following figures.
  • FIGS. 2a and 2b show top views according to the first embodiment, wherein a lid 4 has been omitted in both figures in order to illustrate the interior of the storage container.
  • a separating device 40 is arranged in a receiving space defined by the circular cylindrical section 11 of the housing. This comprises a central main section 48 and a plurality of projections 42 arranged on the main section 48. These projections 42 can be formed in one piece with the main section, but it is also possible for them to be detachable components can be fastened to the main section 48.
  • a medicament channel 41 is formed between two projections 42, via which medicament portions arranged in the storage container one (in Figure 2a shown) delivery channel 21 can be supplied.
  • the main section 48 of the separating device 40 comprises a conical surface 43 with four depressions 44 which are formed radially on the channels 41 and are intended to support the delivery of medicament portions to the medicament channels.
  • the projections are not designed as sections of a circular hollow cylinder, but are withdrawn or flattened in the middle section (relative to the axis of rotation), i.e. in these areas there is a gap between the projections and the inner wall of the circular cylindrical section 11 of the housing (The exact configuration of the projections in relation to the circular cylindrical section is described in more detail below).
  • the separating device shown in the top view is also omitted and the bottom surface 20 can be seen with a dispensing opening 21 and a circular recess 22. Via the dispensing opening, medicament portions arranged in the medicament channels 41 are dispensed when a dispensing channel is aligned with the dispensing opening.
  • the circular recess 22 is provided for receiving medicament dust that arises when the medicament portions are separated.
  • a circular opening is provided in which a coupling device 30 is arranged, via which the separating device can be coupled to a drive which, in the embodiment shown, is not arranged in the storage container.
  • the coupling device itself can be designed in one piece with the separating device, but usually the separating device and the coupling device are detachably connected to one another, to enable the separation device to be exchanged quickly without a coupling device.
  • Figures 3a and 3b show an oblique view and a side view of a section through the first embodiment of the storage container according to the invention, wherein, as in particular Figure 3a it can be seen that the cut is made in such a way that it cuts through the separating device 40 between the medicament channels 41.
  • a gap is provided between an inner wall 3 of the circular cylindrical section 11 of the housing 10 and an outer jacket surface 461 of a central section 46 of a projection 42, through which medicament dust can trickle down onto the bottom surface 20 (the exact structure of the projections is referenced with reference to FIG described on the following figures).
  • a slot is made in the area of the bottom opening 21 in the circular cylindrical section, through which a retaining section 51 of a retaining means 50 is introduced.
  • the retaining section prevents, when a drug channel is aligned at the dispensing opening, drug portions arranged above the drug channel from being dispensed through the channel; only the drug portion contained in the channel upon alignment is indicated.
  • Figures 4a and 4b also show two sectional views, the section being orthogonal to that of FIGS Figures 3a and 3b is led. Also based on the Figures 4a and 4b it can be seen that a gap is formed between the inner wall 3 of the circular cylindrical section 11 and a lateral surface 461 of the central section of a projection. Like it the Figures 3a and 3b As can also be seen from FIGS. 4a and 4b, the bottom surface 20 is designed sloping towards the center and comprises a recess 22 so that medicament dust trickling down through the gap can reach the recess 22 via the sloping bottom surface. Furthermore is the Figures 4a and 4b it can be seen that the lower surface 49 of the separating device is also formed at an angle, so that a gap is formed between the bottom surface 20 and the separating device, through which medicament dust can reach the recess 22.
  • the separating device comprises four channels 41 which are defined by four projections 42.
  • the main body 48 extends beyond the projections 42, ie in the area of the projections a circumferential depression is formed which supports the feeding of the medicament portions into the channels 41.
  • the separating device 40 comprises a conical upper surface 43 with four depressions 44 which are aligned with the medicament channels. Aligned with the recesses 44 and the medicament channels 41, recesses 44a are formed in the main body 48, which interact with the Wells 44 support the delivery of medicament portions into the medicament channels 41.
  • the projections 42 each comprise two end sections 45 with lateral surfaces 451 and central sections 46 with lateral surfaces 461
  • Figures 5e and 5f it can already be seen that the projections are not circular arc-shaped in relation to the central axis of rotation, but that the central sections are reduced in this regard, ie the radius of the central sections is smaller than the radius of the end sections. This is explained in more detail with reference to the following figures.
  • Figures 6a and 6b show the arrangement of the separating device 40 in the circular cylindrical guide space with the inner wall 3 provided by the guide section 11.
  • the separating device comprises four channels 41 and four projections 42 Figures 6a and 6b
  • the projections in the area of the end sections 45 with lateral surfaces 451 rest on the wall of the guide section 11, whereas a lateral surface 461 of a central section 46 of a projection does not rest on the wall, but rather a gap is formed between the lateral surface and the wall. Via this gap, the medicament dust produced during the separation can pass the separation device onto the bottom surface of the storage container.
  • the radius RMA that is to say the distance between the lateral surface and the central axis of rotation DA
  • the radius RMI that is to say the distance between the lateral surface and the central axis of rotation DA
  • FIG. 11 shows a plan view of a second embodiment of a separating device, which is designed essentially in accordance with the first embodiment, with the exception that only three medicament channels 41 are provided. The remaining versions correspond to the first embodiment.
  • Figure 9 shows a third embodiment of the separating device, with both end sections of a projection protruding from the middle section in this embodiment as well, ie the radius RMA at the end sections 45 is greater than the radius RMI at the middle sections 46 central axis of rotation formed in the shape of a circular arc and rises gently in the transition area to the end sections.
  • the middle section can also be formed in that it is not arcuate, but simply a straight line is formed between the end sections, which would lead to a gap with a different shape.
  • Figure 10 shows a fourth embodiment of the separating device.
  • this embodiment only one of the end sections of a projection protrudes with respect to the central section, ie the radius RMA is only greater than the radius RMI of the central section in one of the end sections.
  • the “other” end section 47 is designed in exactly the same way as the central section, ie the lateral surface 471 is formed in the area corresponding to the lateral surface 461 of the central section.
  • the separating device When separating drug portions, the separating device is regularly rotated clockwise according to the embodiment shown, ie the protruding end sections run "in front of" a drug channel towards the dispensing opening (the one in the embodiment shown below the right drug channel is arranged). When rotating counterclockwise, the projecting end sections 45 follow the drug channels. The edges of the projecting end sections 45 formed in the embodiment shown are suitable at the transition between the end section and the medicament channel to detach medicament dust adhering to the wall therefrom. With an appropriately designed separating device, it is therefore possible to detach at least part of the medicament dust adhering to the wall by briefly rotating counterclockwise and to feed it to the bottom surface and, if necessary, to a recess therein. In this way, excessive deposition of drug dust on the wall can be avoided, and a constant increase in the friction between the separating device and the wall is avoided.
  • the design of the projections according to the invention also ensures in all four embodiments that the friction between the separating device and the wall is reduced due to the reduced contact surface wall / outer surface compared to storage containers according to the prior art.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Basic Packing Technique (AREA)

Claims (7)

  1. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament, présentant :
    un boîtier (10) entourant un espace récepteur (2) pour des portions de médicament et doté d'une section de guidage (11) et d'une surface de fond (14), une paroi intérieure (3) de la section de guidage (11) définissant un espace de guidage de forme cylindrique circulaire et la surface de fond (14) présentant une ouverture de distribution (15),
    un dispositif d'individualisation (40) disposé dans la section de guidage (11) du boîtier (10) et ayant un axe de rotation central (DA), le dispositif d'individualisation (40) présentant une section principale (48) et une pluralité de saillies (42), chaque saillie (42) présentant deux sections terminales (45) et une section médiane (46) et un canal à médicament (41) étant respectivement constitué entre deux sections terminales (45) de saillies voisines,
    caractérisé en ce que les sections médianes (46) des saillies (42) sont en retrait par rapport à au moins une des sections terminales (45) et que l'au moins une section terminale (45) de chaque saillie (42) est réalisée de manière à ce que sa surface d'enveloppe (451) repose au niveau de la paroi (3) de la section de guidage (11).
  2. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament selon la revendication 1, caractérisé en ce que les sections terminales (45) dont les surfaces d'enveloppe (451) au niveau de la paroi (3) de la section de guidage (11) sont réparties uniformément pour toutes les saillies (42).
  3. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament selon la revendication 1, caractérisé en ce que les deux sections terminales (45) d'une saillie (42) sont réalisées de manière à reposer au niveau de la paroi (3) de la section de guidage.
  4. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament selon une des revendications 1 à 3, caractérisé en ce que les sections terminales (45) reposant au niveau de la paroi (3) de la section de guidage (11) des saillies (42) sont réparties symétriquement sur le dispositif d'individualisation (40).
  5. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament selon une des revendications 1 à 4, caractérisé en ce que les saillies (42), du moins au niveau de la section médiane (46), dans le cas d'une surface d'enveloppe (461) tournée vers la paroi (3), présentent un revêtement antiadhésif.
  6. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament selon une des revendications 1 à 5, caractérisé en ce que le dispositif d'individualisation (40) présente une surface conique (43) dotée d'une pluralité de creux (44) orientés vers les canaux à médicament (41).
  7. Réservoir de stockage (1) pour station de stockage et de distribution de portions de médicament selon une des revendications 1 à 6, caractérisé en ce que la section principale (48) présente des retraits (44a) au-dessus des canaux à médicament (41).
EP18191874.9A 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament Active EP3616675B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP18191874.9A EP3616675B1 (fr) 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament
JP2021510868A JP7304938B2 (ja) 2018-08-31 2019-05-24 製薬の貯蔵及び分配ステーション用貯蔵容器
CN201980056289.XA CN112638346B (zh) 2018-08-31 2019-05-24 用于药品份的储存及分配站的储存容器
KR1020217005501A KR102694096B1 (ko) 2018-08-31 2019-05-24 약품용 보관 및 분배 스테이션을 위한 보관 용기
PCT/EP2019/063515 WO2020043334A1 (fr) 2018-08-31 2019-05-24 Réservoir pour une station de réserve et de distribution pour médicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18191874.9A EP3616675B1 (fr) 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament

Publications (2)

Publication Number Publication Date
EP3616675A1 EP3616675A1 (fr) 2020-03-04
EP3616675B1 true EP3616675B1 (fr) 2021-04-14

Family

ID=63452479

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18191874.9A Active EP3616675B1 (fr) 2018-08-31 2018-08-31 Réservoir de stockage pour une station de stockage et de distribution pour médicament

Country Status (5)

Country Link
EP (1) EP3616675B1 (fr)
JP (1) JP7304938B2 (fr)
KR (1) KR102694096B1 (fr)
CN (1) CN112638346B (fr)
WO (1) WO2020043334A1 (fr)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2227167A (en) * 1939-07-14 1940-12-31 Morton Salt Co Dispenser for tablets
US2572995A (en) * 1946-03-26 1951-10-30 Allen S Dunbar Antenna
TW557277B (en) * 2001-09-30 2003-10-11 Yuyama Mfg Co Ltd Medicine packing apparatus
JP4250677B2 (ja) * 2002-04-25 2009-04-08 株式会社海渡 カプセル入り商品販売機
GB0315509D0 (en) * 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
DE102006027521B4 (de) * 2006-06-10 2016-01-07 Edwin Kohl Anlage zur personenbezogenen Bestückung von Medikamentenspendern
CN102770348B (zh) * 2010-03-01 2014-07-30 株式会社汤山制作所 药剂分配器的除粉装置
CN103979125B (zh) * 2010-05-17 2015-12-09 株式会社汤山制作所 药片盒
NL2007384C2 (nl) 2011-09-09 2013-03-12 Ppm Engineering B V Systeem en werkwijze voor het verpakken van gedoseerde hoeveelheden vaste medicijnen.
ES2573684T3 (es) * 2012-08-31 2016-06-09 Carefusion Switzerland 317 Sarl Estación de almacenamiento y dosificación para almacenar y dispensar cantidades dosificadas de porciones de fármaco sólido
KR101449717B1 (ko) * 2013-01-02 2014-10-15 주식회사 인포피아 약제 포장장치용 정제 카트리지
WO2015052797A1 (fr) * 2013-10-09 2015-04-16 株式会社タカゾノテクノロジー Dispositif de remplissage de médicament
GB2531996B (en) * 2014-10-20 2018-01-17 Trig1 Ltd Dispensing container with contents level indication
EP3199141A1 (fr) * 2016-01-29 2017-08-02 Becton Dickinson Rowa Germany GmbH Réservoir pour une station de distribution et de stockage de médicaments
TWI724134B (zh) * 2016-03-25 2021-04-11 日商湯山製作所有限公司 片劑盒用轉子以及片劑盒
US10255524B2 (en) * 2016-06-03 2019-04-09 Becton Dickinson Rowa Germany Gmbh Method for providing a singling device of a storage and dispensing container
US10380824B2 (en) * 2017-02-03 2019-08-13 Becton Dickinson Rowa Germany Gmbh Storage and dispensing station for blister packaging machine
EP3358538B1 (fr) * 2017-02-03 2022-03-30 Becton Dickinson Rowa Germany GmbH Station du stockage et distribution pour machine á blisters

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
JP2022500103A (ja) 2022-01-04
CN112638346A (zh) 2021-04-09
JP7304938B2 (ja) 2023-07-07
KR20210049105A (ko) 2021-05-04
CN112638346B (zh) 2024-05-28
KR102694096B1 (ko) 2024-08-09
EP3616675A1 (fr) 2020-03-04
WO2020043334A1 (fr) 2020-03-05

Similar Documents

Publication Publication Date Title
EP3925590B1 (fr) Récipient de stockage pour une station de distribution et de stockage
DE3913437C2 (de) Münzsortierer
EP2962956B1 (fr) Réservoir pour un dispositif destiné à la distribution automatique de portions individuelles de médicaments
EP2987395B1 (fr) Disque de dosage d'un appareil de distribution pour un matériau granulaire
EP2130612A2 (fr) Dispositif de tri de capsules de médicaments erronés
EP3440908A1 (fr) Ensemble de conversion pour un dispositif de séparation pour matériau granulaire
EP3389022A1 (fr) Réservoir pour une station de distribution et de stockage
EP3578157A1 (fr) Machine de remplissage de capsule destiné à remplir des capsules et unité de nettoyage destinée à être à l'utilisation dans une machine de remplissage de capsules
EP1988039B1 (fr) Alimentateur à canal vibrant
WO2018141497A1 (fr) Station de stockage et de distribution pour un automate d'emballages thermoformés
EP3421381B1 (fr) Dispositif de centrage
EP3616675B1 (fr) Réservoir de stockage pour une station de stockage et de distribution pour médicament
WO2021254738A1 (fr) Contenant de stockage destiné à une station de stockage et de distribution
EP3340763B1 (fr) Dispositif de dosage de matière granulaire avec une unité de pré-dosage
EP3463731B1 (fr) Plaquette de coupe pour un outil de fraisage et outil de fraisage
EP3407854A1 (fr) Réservoir destiné à une station de stockage et de délivrance de médicaments
DE2145915A1 (fr)
EP4067245B1 (fr) Station de stockage et de distribution pour un distributeur automatique de blister
DE102007008047B4 (de) Vorrichtung zum geordneten Zuführen von Produkten wie Tabletten, Kapseln, Oblongs oder dergleichen in die Näpfe einer Blisterfolie
EP3156338B1 (fr) Reservoir pour une station de distribution et de stockage de medicaments
EP3926594A1 (fr) Récipient de stockage pour une station de distribution et de stockage
EP3879503A1 (fr) Station de stockage et de distribution de médicaments
EP4434903A1 (fr) Réservoir pour une station de stockage et de distribution pour une machine à blisters et procédé pour séparer des produits en petites pièces
EP3945504B1 (fr) Récipient de stockage pour une station de distribution et de stockage
EP3621794A1 (fr) Dispositif de fabrication d'un produit d'emballage tridimensionnel, tel qu'un produit rembourré, à partir d'une bande de papier monocouche ou multicouche

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200626

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210114

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502018004781

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1381646

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210515

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210714

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210714

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210816

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210814

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210715

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502018004781

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20220117

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210814

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240723

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210414

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240723

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240723

Year of fee payment: 7

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 1381646

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230831

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240723

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230831